Assistant Attorney General Warns of Heightened FCPA Enforcement Against Pharmaceutical Industry 11/17/09
The Department of Justice is turning up the heat even further on the pharmaceutical industry to comply with the Foreign Corrupt Practices Act (“FCPA”). In a speech on November 12 to the Tenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, Lanny A. Breuer, Assistant Attorney General of DOJ’s Criminal Division, bluntly warned an audience of pharmaceutical industry officials that “[o]ur focus and resolve in the FCPA will not abate, and ...
To view the complete article, please login or subscribe if you don't already have an account.